IL18 and metabolic syndrome: In the present cohort, obesity-linked variables, such as diabetes, dyslipidemia (low HDL cholesterol and high triglyceride levels) and elevations in systemic inflammatory markers (CRP, IL-6 and IL-18), were more common among individuals with complete fatty degeneration of thymus.